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Osteopontin (secreted phosphoprotein 1; SPP1) expression has
been identified in human lung cancer and has been linked with
enhanced tumour progression. To examine its functional role, we
induced lung tumours by repetitive urethane or MCA/BHT lung
carcinogens in C57BL/6 mice lacking both (Spp1-/-), one (Spp1
+/-), or no (Spp1+/+) copy of the endogenous Spp1 gene. Pri-
mary end-points were lung tumour number and size; secondary
end-points were SPP1 expression, epithelial cell survival, carcino-
gen-induced inflammation, and angiogenesis. Data are presented
as mean ± SD.
Compared with Spp1+/+ mice (n = 22), Spp1-/- mice
(n = 25) developed dramatically fewer and significantly smaller
lung tumours in response to urethane, while Spp1± mice
(n = 12) behaved similar to Spp1-/- mice (number/diameter of
lung tumours in Spp1+/+, Spp1+/-, and Spp1-/- mice, respec-
tively: 16.1 ± 12.7/1.2 ± 0.3 mm, 2.4 ± 2.3/0.9 ± 0.2 mm, and
1.3 ± 1.6/0.7 ± 0.2 mm; P < 0.05 for comparison of Spp1+/+
with Spp1-/- and Spp1+/- mice). Spp1-/- mice were also protected
from two-hit MCA/BHT-oncogenesis compared with Spp1+/+
controls. Spp1-/- mice displayed decreased epithelial cell survival
and reduced numbers of airspace macrophages early after ure-
thane, and enhanced tumour cell apoptosis and limited tumour
angiogenesis at late stages of lung tumour progression. SPP1 was
expressed in the naïve lung by non-ciliated airway epithelial cells
and alveolar macrophages and was significantly up-regulated dur-
ing multi-stage lung carcinogenesis.
Our data indicate that SPP1 is functionally involved in airway
epithelial carcinogenesis and may present a target for lung cancer
treatment and prevention.
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